Genetic, environmental, and pharmacological determinants of telomere attrition rates: Implications for the prevention of age-related multimorbidity

点击翻译按钮获取中文摘要

The UK Office for National Statistics estimates that in 50 years' time, there will be an additional 8.6 million people aged 65 years and over. Longer lifespan has clear benefits, but when it is associated with an increased proportion of the population suffering from age-related diseases, it can pose a burden to individual sufferers and to the economy. Telomeres are 'DNA tails' at the end of chromosomes that shorten as we age. Premature telomere shortening is hypothesized to predispose individuals to multiple age-related diseases, including coronary artery disease and rheumatoid arthritis. This is because cells with very short telomere lengths are less able to divide and replace old, damaged or unhealthy cells within tissues. Interestingly, there is evidence that the rate of telomere shortening can be affected by genetic, environmental and pharmacological factors. A deeper understanding of which specific factors affect rates of telomere shortening might allow us to pinpoint individuals at high risk of specific age-related diseases or clusters of age-related diseases, and identify new ways of preventing or delaying their onset. Within this grant, I will make use of telomere length data generated from half a million adults in the UK, to determine: (a) which genetic factors affect the rate at which our telomeres shorten, (b) how faster telomere shortening impacts on risk for different types of diseases, (c) whether specific environmental or lifestyle factors (e.g. exercise, diet) can protect from faster telomere shortening and diseases in late adulthood, (d) whether existing drugs might slow telomere shortening and be repurposed as anti-ageing compounds.